Role of NAD(P)H:quinone oxidoreductase in the progression of neuronal cell death in vitro and following cerebral ischaemia in vivo

Journal of Neurochemistry

Volumn 84, Issue 5, 2003, Pages 1028-1039

  Kapinya, Krisztian J ^a   Harms, Ulrike ^a   Harms, Christoph ^a   Blei, Katharina ^a   Katchanov, Juri ^a   Dirnagl, Ulrich ^a   Hörtnagl, Heide ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Apoptosis; Brain; Dicoumarol; NAD(P)H:quinone oxidoreductase; Oxidative stress; Stroke

Indexed keywords

CHRYSIN; CIBACRON BLUE F3GA; DICOUMAROL; ETHYLCHOLINE MUSTARD AZIRIDINIUM; GLUCOSE; LACTATE DEHYDROGENASE; NEUROPROTECTIVE AGENT; OXYGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (QUINONE); TERT BUTYLHYDROQUINONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE COURSE; EMBRYO; ENZYME ACTIVITY; ENZYME LOCALIZATION; GLIA CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; AZIRIDINES; BRAIN ISCHEMIA; CELLS, CULTURED; CHOLINE; DICUMAROL; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DRUG SYNERGISM; ENZYME ACTIVATION; ENZYME INHIBITORS; HYDROQUINONES; MALE; MICE; MICE, INBRED C57BL; NAD(P)H DEHYDROGENASE (QUINONE); NADPH DEHYDROGENASE; NEURONS; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0037340791     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01601.x     Document Type: Article

References (60)

1. Ahlgren-Beckendorf J. A., Reising A. M., Schander M. A., Herdler J. W. and Johnson J. A. (1999) Coordinate regulation of NAD(P)H: quinone oxidoreductase and glutathione-S-transferase in primary cultures of rat neurons and glia: role of the antioxidant/electrophile responsive element. Glia 25, 131-142.
2. Asher G., Lotem J., Cohen B., Sachs L. and Shaul Y. (2001) Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc. Natl Acad. Sci. USA 98, 1188-1193.
3. Banasiak K. J. and Haddad G. G. (1998) Hypoxia-induced apoptosis: effect of hypoxic severity and role of p53 in neuronal cell death. Brain Res. 797, 295-304.
4. Beyer R. E., Segura-Aguilar J., Di Bernardo S., Cavazzoni M., Fato R., Fiorentini D., Galli M. C., Setti M., Landi L. and Lenaz G. (1996) The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems. Proc. Natl Acad. Sci. USA 93, 2528-2532.
5. Brewer G. J. (1995) Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum and dendate gyrus. J. Neurosci. Res. 42, 674-683.
6. Bruer U., Weih M. K., Isaev N. K., Meisel A., Ruscher K., Bergk A., Trendelenburg G., Wiegand F., Victorov I. V. and Dirnagl U. (1997) Induction of tolerance in rat cortical neurons: hypoxic preconditioning. FEBS Lett. 414, 117-121.
7. Cadenas E. (1995) Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism. Biochem. Pharmacol. 49, 127-140.
8. Campagne M. V., Thibodeaux H., van Bruggen N., Calms B. and Lowe D. G. (2000) Increased binding activity at an antioxidant-responsive element in the metallothionein-1 promoter and rapid induction of metallothionein-1 and -2 in response to cerebral ischemia and reperfusion. J. Neurosci. 20, 5200-5207.
9. Chen S., Hwang J. and Deng P. S. K. (1993) Inhibition of NAD(P)H:quinone acceptor oxidoreductase by flavones: a structure-activity study. Arch. Biochem. Biophys. 302, 72-77.
10. Chen S., Wu K., Zhang D., Shermann M., Knox R. and Yang C. S. (1999) Molecular characterization of binding of substrates and inhibitors to DT-diaphorase: combined approach involving site-directed mutagenesis, inhibitor-binding analysis, and computer modeling. Mol. Pharmacol. 56, 272-278.
11. Chesis P. L., Levin D. E., Smith M. D., Emster L. and Ames B. N. (1984) Mutagenicity of quinones: pathways of metabolic activation and detoxification. Proc. Natl Acad. Sci. USA 81, 1696-1700.
12. Cross J. V., Deak J. C., Rich E. A., Qian Y., Lewis M., Parrott L. A., Mochida K., Gustafson D., Pol S. V. and Templeton D. J. (1999) Quinone reductase inhibitors block SAPK/JNK and NFκB pathways and potentiate apoptosis. J. Biol. Chem. 274, 31150-31154.
13. Crumrine R. C., Thomas A. L. and Morgan P. F. (1994) Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. J. Cereb. Blood Flow Metab. 14, 887-891.
14. Culmsee C., Zhu X., Yu Q. S., Chan S. L., Camandola S., Guo Z., Greig N. H. and Mattson M. P. (2001) A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. J. Neurochem. 77, 220-228.
15. Dinkova-Kostova A. T. and Talalay P. (2000) Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen. Free Rad. Biol. Med. 29, 231-240.
16. Duffy S., So A. and Murphy T. H. (1998) Activation of endogenous antioxidant defenses in neuronal cells prevents free radical-mediated damage. J. Neurochem. 71, 69-77.
17. Eftekharpour E., Holmgren A. and Juurlink B. H. (2000) Thioredoxin reductase and glutathione synthesis is upregulated by t-butylhydroquinone in cortical astrocytes but not in cortical neurons. Glia 31, 241-248.
18. Fisher A., Mantione C. R., Abraham D. J. and Hanin I. (1982) Long-term central cholinergic hypofunction in mice by ethylcholine aziridinium ion (AF64A) in vivo. J. Pharmacol. Exp. Ther. 222, 140-145.
19. Gorelick P. B., Sacco R. L., Smith D. B., Alberts M., Mustone-Alexander L., Rader D., Ross J. L., Raps E., Ozer M. N., Brass L. M., Malone M. E., Goldberg S., Booss J., Hanley D. F., Toole J. F., Greengold N. L. and Rhew D. C. (1999) prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA 281, 1112-1120.
20. Gottron F. J., Ying H. S. and Choi D. W. (1997) Caspase inhibition selectively reduces the apoptotic component of oxygen-glucose deprivation-induced cortical neuronal cell death. Mol. Cell Neurosci. 9, 159-169.
21. Hanin I. (1996) The AF64A model of cholinergic hypofunction: An update. Life Sci. 58, 1955-1964.
22. Hara H., Huang H., Panahian N., Fishman M. C. and Moskowitz M. A. (1996) Reduced brain edema and infarction Volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. J. Cereb. Blood Flow Metab. 16, 605-611.
23. Harms C., Lautenschlager M., Bergk A., Freyer D., Weih M., Dirnagl U., Weber J. R. and Hörtnagl H. (2000) Melatonin is protective in necrotic but not in caspase-dependent, free radical-independent apoptotic neuronal cell death in primary neuronal cultures. FASEB J. 14, 1814-1824.
24. Harms C., Lautenschlager, M., Bergk A., Katchanov J., Freyer D., Kapinya K., Herwig U., Megow D., Dirnagl U., Weber J. R. and Hörntagl H. (2001) Differential mechanisms of neuroprotection by 17 D-estradiol in apoptotic versus necrotic neurodegeneration. J. Neurosci. 21, 2600-2609.
25. Hoult J. R. S. and Paya M. (1996) Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. Gen. Phamacol. 27, 713-722.
26. Huggins C., Ueda N. and Russo A. (1978) Azo dyes prevent hydro-carbon-induced leukemia in the rat. Proc. Natl Acad. Sci. USA 75, 4524-4527.
27. Iwata-Ichikawa E., Kondo Y., Miazaki I., Asanuma M. and Ogawa N. (1999) Glial cells protect neurons against oxidative stress via transcriptional up-regulation of the glutathione synthesis. J. Neurochem. 72, 2334-2344.
28. Koh J. Y. and Choi D. W. (1987) Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Methods 20, 83-90.
29. Krause D., Lyons A., Fennelly C. and O'Connor R. (2001). Transient activation of Jun N-terminal kinases and protection from apoptosis by the insulin-like growth factor 1 receptor can be suppressed by dicumarol. J. Biol. Chem. 276, 19244-19252.
30. Landi F., Fiorentini D., Galli M. C., Segura-Aguilar J. and Beyer R. E. (1997) DT-Diaphorase maintains the reduced state of ubiquinons in lipid vesicles thereby promoting their antioxidant function. Free Rad Biol. Med. 22, 329-335.
31. Lautenschlager M., Onufriev M. V., Gulyaeva N. V., Harms C., Freyer D., Sehmsdorf U.-S., Ruscher K., Moiseeva Y. V., Arnswald A., Victorov I., Dirnagl U., Weber J. R. and Hörtnagl H. (2000) Role of nitric oxide in the ethylcholine aziridinium (AF64A) model of delayed apoptotic neurodegeneration in vivo and in vitro. Neuroscience 97, 383-393.
32. Laxton A. W., Sun M. C., Shen H., Murphy T. H. and Honey C. R. (2001) The antioxidant enzyme quinone reductase is upregulated in vivo following cerebral ischemia. Neuroreport 12, 1045-1058.
33. Li Y. and Jaiswal A. K. (1993) Regulation of human NAD(P)H: quinone oxidoreductase gene. Role of API binding site contained within the human antioxidant response element. J. Biol. Chem. 267, 15097-15104.
34. Li R., Bianchet M. A., Talalay P. and Arnzel L. M. (1995) The three-dimensional structure of NAD(P)H: quinone reductase, a flavo-protein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction. Proc. Natl Acad. Sci. USA 92, 8846-8850.
35. Moehlenkamp J. D. and Johnson J. A. (1999) Activation of antioxidant electrophile responsive elements in IMR-32 human neuroblastoma cells. Arch. Biochem. Biophys. 363, 98-106.
36. Murphy T. H., De Long M. J. and Coyle J. T. (1991) Enhanced NAD(P)H: Quinone reductase activity prevents glutamate toxicity produced by oxidative stress. J. Neurochem. 56, 990-995.
37. Murphy T. H., So A. P. and Vincent S. R. (1998) Histochemical detection of quinone reductase activity in situ using LY 83583 reduction and oxidation. J. Neurochem. 70, 2156-2164.
38. Murphy T. H., Yu J., Ng R., Johnson D. A., Shen H., Honey C. R. and Johnson J. A. (2001) Preferential expression of antioxidant response element mediated gene expression in astrocytes. J. Neurochem. 76, 1670-1678.
39. Ngo E. O., Nutter L. M., Sura T. and Gutierrez P. L. (1998) Induction of p53 by the concerted actions of aziridine and quinone moieties of diaziquone. Chem. Res. Toxicol. 11, 360-368.
40. Page G. K. and Morton A. J. (1995) Correlation of neuronal cell loss with increased expression of NADPH diaphorase in cultured rat cerebellum and cerebral cortex. Brain Res. 697, 157-168.
41. Pink J. J., Planchon S. M., Tagliarino C., Varnes M. E., Siegel D. and Boothman D. A. (2000) NAD(P)H: quinone oxidoreductase activity is the principal determinant of β-lapachone cytotoxicity. J. Biol. Chem. 275, 5416-5424.
42. Planchon S. M., Pink J. J., Tagliarino C., Bommann W. G., Varnes M. E. and Boothman D. A. (2001) β-Lapachone-induced apoptosis in human prostate cancer cells: Involvement of NQO1/xip3. Exp. Cell Res. 267, 95-106.
43. Polyak K., Xia Y., Zweier J. L., Kinzler K. W. and Vogelstein B. (1997) A model for p53-induced apoptosis. Nature 389, 300-305.
44. Prange O., Johnson J. A., Johnson D. A. and Murphy T. H. (1999) Preferential expression of antioxidant response element mediated gene expression in cortical astrocytes. Soc. Neurosci. Abstr. 25, 837.5.
45. Prestera T., Prochaska H. J. and Talalay P. (1992) Inhibition of NAD(P)H: (quinone-acceptor) oxidoreductase by cibacron blue and related anthraquinone dyes: a structure-activity study. Biochemistry 31, 824-833.
46. Prestera T., Zhang Y., Spencer S. R., Wilczak C. A. and Talalay P. (1993) The electrophile counterattack response: protection against neoplasia and toxicity. Adv. Enzyme Regul. 33, 281-296.
47. Prochaska H. J. and Santamaria A. B. (1988) Direct measurement of NAD(P)H: quinone reductase from cells cultured in microtiter wells: a screening assay for anticarcinogenic enzyme inducers. Anal. Biochem. 169, 328-336.
48. Raina A. K., Templeton D. J., Deak J. C., Perry G. and Smith M. A. (1999) Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease. Redox Report 4, 23-27.
49. Rinner W. A., Pifl C., Lassmann H. and Hörtnagl H. (1997) The induction of apoptosis in vitro and in vivo by the cholinergic neurotoxin ethylcholine aziridinium. Neuroscience 79, 535-542.
50. Sarlauskas J., Dickancaité E., Nemeikaité A., Anusevicius Z., Nivinskas H., Segura-Aguilar J. and Cénas N. (1997) Nitrobenzimidazoles as substrates for DT-diaphorase and redox cycling compounds: their enzymatic reactions and cytotoxicity. Arch. Biochem. Biophys. 346, 219-229.
51. Siemankowski L. M., Morreale J., Butts B. D. and Briehl M. M. (2000) Increased tumor necrosis factor-α sensitivity of MCF-7 cells transfected with NAD(P)H: quinone reductase. Cancer Res. 60, 3638-3644.
52. Stapf C. and Mohr J. P. (2002) Ischemic stroke therapy. Ann. Rev. Med. 53, 453-475.
53. Swanson A. R., Morton M. T., Tsao-Wu G., Savalos R. A., Davidson C. and Sharp F. R. (1990) A semiautomated method for measuring brain infarct volume. J. Cereb. Blood Flow Metab. 10, 290-293.
54. Traver R. D., Siegel D., Beall H. D., Phillips R. M., Gibson N. W., Franklin W. A. and Ross D. (1997) Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). Br. J. Cancer 75, 69-75.
55. Trendelenburg G., Prass K., Priller J., Kapinya K., Polley A., Muselmann C., Ruscher K., Kannbley U., Schmitt A. O., Castell S., Wiegand F., Meisel A., Rosenthal A. and Dirnagl U. (2002) Serial analysis of gene expression identifies metallthionein II as major neuroprotective gene in mouse focal cerebral ischemia. J. Neurosci. 22, 5879-5888.
56. Valerio L. G., Kepa J. K., Pickwell G. V. and Quattrochi L. C. (2001) Induction of human NAD(P)H: quinone oxidoreductase-(NQO1) gene expression by the flavonol quercitin. Toxicol. Lett. 119, 49-57.
57. Vervoort L. M., Ronden J. E. and Thijssen H. H. (1997) The potent antioxidant activity of the vitamin K cycle in microsomal lipid peroxidation. Biochem. Pharmacol. 54, 871-876.
58. Wang Y., Santa-Cruz K., DeCarli C. and Johnson J. A. (2000) NAD(P)H: quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with Alzheimer's disease. Neurobiol. Aging 21, 525-531.
59. Wu K., Knox R., Sun X. Z., Joseph P., Jaiswal A. K., Zhang D., Deng P. S.-K. and Chen S. (1997) Catalytic properties of NAD(P)H: quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase. Arch. Biochem. Biophys. 347, 221-228.
60. Zhao Q., Yang X. L., Holtzclaw W.D. and Talalay P. (1997) Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H: quinone reductase (DT-diaphorase). Proc. Natl Acad. Sci. 94, 1669-1674.